Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR.

Source:http://linkedlifedata.com/resource/pubmed/id/15770208

Br. J. Cancer 2005 Mar 28 92 6 1069-77

Download in:

View as

Triples

General Info

PMID
15770208